Clinical features, epidemiology, antimicrobial resistance, and exotoxin genes (including that of Panton-Valentine leukocidin) of gentamicin-susceptible methicillin-resistant Staphylococcus aureus (GS-MRSA) isolated at a paediatric teaching hospital in New South Wales, Australia

Pathology

Volumn 40, Issue 1, 2008, Pages 64-71

  Gubbay, Jonathan B ^a,d   Gosbell, Iain B ^b,c   Barbagiannakos, Thelma ^b   Vickery, Alison M ^b   Mercer, Joanne L ^b   Watson, Michael ^a,e  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e Clinipath Pathology   (Australia)

Author keywords

Methicillin (oxacillin) resistance; Panton Valentine leukocidin; PFGE; Phage typing; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ENTEROTOXIN; ERYTHROMYCIN; EXOTOXIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; PANTON VALENTINE LEUKOCIDIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BACTERIOPHAGE; CHILD; CHILD CARE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PEDIATRIC HOSPITAL; PNEUMONIA; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

EID: 36448971550     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701716276     Document Type: Article

References (36)

1. Hussain FM, Boyle-Vavra S, Bethel CD, Daum RS. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000; 19: 1163-6.
2. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 2001; 20: 860-3.
3. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney. Pathology 2001; 33: 206-10.
4. Nimmo GR, Coombs GW, Pearson JC, O'Brien FG, Christiansen KJ, Turnidge JD, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184: 384-8.
5. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-24.
6. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. (See comment.) Clin Infect Dis 1999; 29: 797-800.
7. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus strains producing synergohymenotropic toxins. J Clin Microbiol 2000; 3926-31.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-40.
9. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital. Pediatr Infect Dis J 2004; 23: 619-24.
10. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990; 28: 608-9.
11. Brakstad OG, Maeland JA, Tveten Y. Multiplex polymerase chain reaction for detection of genes for Staphylococcus aureus thermonuclease and methicillin resistance and correlation with oxacillin resistance. APMIS 1993; 101: 681-8.
12. Blair JE, Williams REO. Phage typing of staphylococci. Bull WHO 1961; 24: 771-8.
13. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-32.
14. Becker K, Rothlin RP, Peters G. Rapid and specific detection of toxigenic Staphylococcus aureus: Use of two multilplex PCR enzyme immunoassays for amplification and hybridisation of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol 1998; 36: 2548-53.
15. O'Brien FG, Lim TT, Chong FN, et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 2004; 42: 3185-90.
16. Dice LR. Measures of the amount of ecologic association between species. J Clin Microbiol 1945; 26: 297-302.
17. ETHCON96. Ethnicity Consortium Program for 1996. Census of Population and Housing. Sydney: Census Applications, 1996.
18. Mitchell JM, MacCulloch D, Morris AJ. MRSA in the community. N Z Med J 1996; 110: 411.
19. Coombs GW, Nimmo GR, Bell JM, et al. Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. Clin Microbiol 2004; 42: 4735-43.
20. Australian Census Data, Report. Australian Bureau of Statistics, 2001.
21. O'Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 1999; 37: 2858-62.
22. Riley DD, MacCulloch D, Morris AJ. Methicillin-resistant Staphylococcus aureus in the suburbs. N Z Med J 1998; 111: 59.
23. Maguire GP, Arthur AD, Bousted PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996; 164: 721-3.
24. Baggett HC, Hennessy TW, Leman R, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. (See comment.) Infect Control Hosp Epidemiol 2003; 24: 397-402.
25. Gosbell IB, Mercer JL, Neville SA, et al. Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. (See comment.) Med J Aust 2001; 174: 627-30.
26. Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T. Community-acquired methicillin-resistant Staphylococcus aureus in Australia. Lancet 1998; 352: 145-6.
27. Collins N, Gosbell IB, Wilson S. Community-acquired MRSA bacteraemia. Med J Aust 2002; 177: 55-6.
28. Nimmo GR, Playford EG. Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust 2003; 178: 245.
29. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. (See comment.) JAMA 1998; 279: 593-8.
30. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1208-9.
31. Prevost G, Couppie P, Prevost P. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995; 42: 237-45.
32. Couppie P, Cribier B, Prevost G, Grosshans E, Piemont Y. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 1994; 130: 1208-9.
33. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-9.
34. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-84.
35. Lowe DE. Respiratory tract infections: resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and Gram-negative rods. Infect Dis Clin North Am 1998; 12: 614-30.
36. Frank AL, Marcinak JF, Mangat PD. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21: 530-4.